GlassScriptPhysician profile
Kimberly A Boote
NPI 1538167887
$1,481.83
in general payments reported to CMS, 2019-2025
21 companies · $266 in 2025
The $266 reported for 2025 was more than what 87% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $416 · 2022: $169 · 2023: $327 · 2024: $303 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $896.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $357.21 | 2021-2022 | |
| Biogen, INC. | $235.08 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $135.41 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $131.24 | 2023-2024 | Myfembree |
| Organon LLC | $115.75 | 2021-2024 | Nexplanon |
| Myriad Women'S Health, INC. | $98.07 | 2023 | Myrisk |
| Astellas Pharma US INC | $63.24 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $49.49 | 2021-2022 | |
| Exeltis, USA INC. | $46.94 | 2022-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $37.19 | 2021-2024 | |
| Coopersurgical, INC. | $30.22 | 2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $24.33 | 2024-2025 | |
| Daiichi Sankyo INC. | $23.61 | 2022 | |
| Sanara Medtech INC. | $19.76 | 2025 | Celleraterx |
| Lilly USA, LLC | $19.49 | 2025 | Mounjaro, Zepbound |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.31 | 2021 | |
| Dexcom, INC. | $17.25 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $16.20 | 2023 | Truclear |
| Pfizer INC. | $14.84 | 2023 | |
| Evofem Biosciences, INC. | $14.24 | 2022 | |
| Novo Nordisk INC | $13.96 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Boote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.